FIELD: organic chemistry, pharmacy. SUBSTANCE: invention proposes amino-derivatives of oxo- or hydroxy-substituted hydrazines of formulas: XN(R)CH- --C(O)Y (IC) and XN(R)CH--C(O)Y (ID) where R is H; X is H, (C1-C10)-aryl-(C1-C6)-alkoxycarbonyl and others; R21 is (C6-C10)-aryl-(C1-C6)- -alkyl; R22 is H; R23 is (C1-C6)-alkyl, (C6-C10)-aryl-(C1-C6)-alkyl and others; R24 is H; Y is (C1-C6)-alkyl, (C1-C6)-alkoxy and others. These compounds are synthesized by interaction of compound of the formula X-NR- with compound of the formula HN--C(O)Y. Compounds (IC) and (ID) can be used in pharmaceutical compositions as an active agent to inhibit retrovirus protease, in part, at acquired immunodeficiency syndrome (AIDS) that gives possibility to use these compounds for treatment of patients with viral HIV-infections. EFFECT: improved method of synthesis, enhanced effectiveness of compounds. 11 cl, 3 tbl, 38 ex
Title | Year | Author | Number |
---|---|---|---|
COMPOUNDS | 2008 |
|
RU2461559C2 |
PEPTIDE COMPOUNDS AND METHOD OF PREPARING THEREOF | 1993 |
|
RU2106357C1 |
TETRAHYDROFURO(3,2-b)PYRROL-3-ONES AS CATHEPSIN K INHIBITORS | 2007 |
|
RU2456290C2 |
DERIVATIVES OF PYRROLIDINE, METHOD OF THEIR SYNTHESIS (VARIANTS), PHARMACEUTICAL COMPOSITION, METHOD OF SEPARATION OF ENANTIOMERS AND CHIRAL PHASE FOR SEPARATION OF ENANTIOMERS | 1992 |
|
RU2118316C1 |
ANTIINFLAMMATORY MEDICATIONS | 2004 |
|
RU2365585C2 |
HYDROXYETHYLAMINOSULFONEAMIDES, INTERMEDIATE COMPOUNDS, PHARMACEUTICAL COMPOSITION, METHOD OF INHIBITION RETROVIRAL PROTEASES, METHOD OF TREATMENT OF RETROVIRAL INFECTIONS, METHOD OF TREATMENT OF AIDS | 1993 |
|
RU2173680C2 |
TAXOL DERIVATIVES WITH ANTICANCER ACTIVITY | 2007 |
|
RU2419622C2 |
IMPROVED APELIN RECEPTOR AGONISTS (APJ) AND THEIR USE | 2016 |
|
RU2766148C1 |
QUINOLONE AND ACRIDINE COMPOUNDS, METHODS OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 1993 |
|
RU2124006C1 |
NEW PHOSPHORAMIDATE NUCLEOSIDE DERIVATIVES AND APPLICATION THEREOF | 2014 |
|
RU2621709C2 |
Authors
Dates
1999-02-27—Published
1993-03-11—Filed